Finally, we plan to compare in future studies the efficacy and toxicity of Ad5Δ24-anti-PD-L1-scFv with the commercially available mAbs and, additionally, to evaluate its efficacy in different tumor models characterized by lower T-cell infiltrations. Here, CD274 is linked to neoplasm.